Research Study

A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Non-Infectious Uveitis
Principal Investigator 
Patrick Ma

Overview

Body Locations and Systems 
Uveitis
ClinicalTrials.gov# 
NCT03207815
Status 
Recruiting
Study Start/End 
Oct 16, 2017 to Dec 31, 2020
Locations 
Vancouver General Hospital
Name/Title 
Theresa Wiens, Clinical Research Manager
Phone 
604-875-4111 ext.62544
Purpose of Study 

The primary objective of this study is to evaluate the efficacy of filgotinib versus placebo for the treatment of the signs and symptoms of non-infectious uveitis in participants failing treatment for active non-infectious uveitis.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.